The British Journal of Psychiatry 154: 697-704 (1989)
© 1989 The Royal College of Psychiatrists
FK Taylor
Bethlem Royal Hospital, London.
It is argued that there are two kinds of benzodiazepine dependence: a therapeutic and a morbid kind. The therapeutic dependence is acceptable in that it mitigates the clinical manifestations in patients with long- standing and fluctuating anxious-depressive symptoms. The morbid dependence is an unfortunate complication which can arouse therapeutic concern because it ties patients to an excessive dosage, unless the penalty of a sometimes grim abstinence syndrome is paid on drug reduction. The present, often strident and threatening, damnation of benzodiazepines oversteps the mark and causes avoidable misery to patients whose well-being has become largely and therapeutically dependent on the drug.
This article has been cited by other articles:
![]() |
J. A.E. Fleming, C. H. Samuels, J. MacFarlane, and R. Morehouse Addictive evidence Can Fam Physician, March 1, 2008; 54(3): 346 - 348. [Full Text] [PDF] |
||||
![]() |
L. S. Meredith, C. D. Sherbourne, C. A. Jackson, P. Camp, and K. B. Wells Treatment Typically Provided for Comorbid Anxiety Disorders Arch Fam Med, May 1, 1997; 6(3): 231 - 237. [Abstract] [PDF] |
||||
![]() |
A. Piper Jr Addiction to Benzodiazepines--How Common? Arch Fam Med, November 1, 1995; 4(11): 964 - 970. [Abstract] [PDF] |
||||